
NantKwest
Biotechnology Research
Overview
Overview
Specialty
Cancer, Immunotherapy, Natural Killer Cells, Oncology
Overview
NantKwest (NASDAQ: NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. NK cells a read more company news read more company news read more company news read more company news...
FAQs
What is NantKwest's official website?
NantKwest's official website is http://nantkwest.com.
Find Contacts Everywhere
Find emails and phone numbers on LinkedIn, Company Websites and Your CRM!
